Staff Secondment Form

Please fill in the following

Your Name:

Your Email Address:

Name of the host organisation:

Name of the secondee’s organisation:

Name of the secondee:

Age of the secondee

Sex of the secondee:

Duration of the secondment:

Estimated date of the secondment:

Estimated budget of the secondment (<€2000.00):

Brief description of training to be provided (including relevance to the secondee):

MediTrans Staff Secondment Rules:

Any Personnel from the MediTransConsortium can attend the premises of any other MediTransConsortium Member based upon prior agreement between both organisations.
Each individual secondment should last up to 5 working days.
Secondment activities can include: technology practices, technology demonstrations, discussion forums, working groups etc.
Training at Consortium Members’ own facilities and at external events can be included as a staff secondment, but must be justifiably relevant to the Project.
Applications can be initiated by the secondee or by the host, but must be jointly completed by the secondee and by the host
The evaluators will set a deadline for the completion of the secondment
Initially, secondments will be limited to one per partner organisation
Upon completion of a secondment each secondee is required to complete a one page summary report of their activities which should include; benefits obtained, total cost of secondment and recommendation for future improvements, plus any additional information you feel is relevant.

Click above to confirm that you accept the rules listed above

An Integrated Project funded by the European Commission under the "nanotechnologies and nano-sciences, knowledge-based multifunctional materials and new production processes and devices" (NMP) thematic priority of the Sixth Framework Programme. Contract Number: NMP4-CT-2006-026668

Next Event:
2-3 November 2007

Venue:
North-eastern University, Boston, MA, USA

Description:
Fifth International Nanomedicine and Drug Delivery Symposium (NanoDDS´07)

Information:
www.nanodds.org

The overall aim is to advance health care via the development of innovative targeted drug / imaging agent delivery with controlled release, and imaging guidance procedures for the detection of the underlying targeting / (triggered) drug release processes.

OTHER USEFUL LINKS